Literature DB >> 18760160

The contribution of cognition and spasticity to driving performance in multiple sclerosis.

Thomas D Marcotte1, Theodore J Rosenthal, Erica Roberts, Sara Lampinen, J Cobb Scott, R Wade Allen, Jody Corey-Bloom.   

Abstract

OBJECTIVE: To examine the independent and combined impact of cognitive dysfunction and spasticity on driving tasks involving high cognitive workload and lower-limb mobility in persons with multiple sclerosis (MS).
DESIGN: Single-visit cohort study.
SETTING: Clinical research center. PARTICIPANTS: Participants included 17 drivers with MS and 14 referent controls. The group with MS exhibited a broad range of cognitive functioning and disability. Of the 17 patients with MS, 8 had significant spasticity in the knee used to manipulate the accelerator and brake pedals (based on the Modified Ashworth Scale).
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: A brief neuropsychologic test battery and 2 driving simulations. Simulation 1 required participants to maintain a constant speed and lane position while attending to a secondary task. Simulation 2 required participants to adjust their speed to accelerations and decelerations of a lead car in front of them.
RESULTS: Patients with MS showed greater variability in lane position (effect size, g=1.30), greater difficulty in maintaining a constant speed (g=1.25), and less ability to respond to lead car speed changes (g=1.85) compared with controls. Within the MS group, in a multivariate model that included neuropsychologic and spasticity measures, cognitive functioning was the strongest predictor of difficulty in maintaining lane position during the divided attention task and poor response time to lead car speed changes, whereas spasticity was associated with reductions in accuracy of tracking the lead car movements and speed maintenance.
CONCLUSIONS: In this preliminary study, cognitive and physical impairments associated with MS were related to deficits in specific components of simulated driving. Assessment of these factors may help guide the clinician regarding the types of driving behaviors that would put patients with MS at an increased risk for an automobile crash.

Entities:  

Mesh:

Year:  2008        PMID: 18760160      PMCID: PMC4560356          DOI: 10.1016/j.apmr.2007.12.049

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  20 in total

1.  Assessing the driving performance of older adult drivers: on-road versus simulated driving.

Authors:  Hoe C Lee; Don Cameron; Andy H Lee
Journal:  Accid Anal Prev       Date:  2003-09

2.  Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Raul Gonzalez; Emily Conover; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

3.  A multimodal assessment of driving performance in HIV infection.

Authors:  T D Marcotte; T Wolfson; T J Rosenthal; R K Heaton; R Gonzalez; R J Ellis; I Grant
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

4.  Paced auditory serial-addition task: a measure of recovery from concussion.

Authors:  D M Gronwall
Journal:  Percept Mot Skills       Date:  1977-04

Review 5.  A multimodal approach to managing the symptoms of multiple sclerosis.

Authors:  Heidi Crayton; Rock A Heyman; Howard S Rossman
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

6.  Driving accident frequency increased in patients with multiple sclerosis.

Authors:  S Lings
Journal:  Acta Neurol Scand       Date:  2002-03       Impact factor: 3.209

7.  Visual processing impairment and risk of motor vehicle crash among older adults.

Authors:  C Owsley; K Ball; G McGwin; M E Sloane; D L Roenker; M F White; E T Overley
Journal:  JAMA       Date:  1998-04-08       Impact factor: 56.272

8.  Driving simulation with EEG monitoring in normal and obstructive sleep apnea patients.

Authors:  M R Risser; J C Ware; F G Freeman
Journal:  Sleep       Date:  2000-05-01       Impact factor: 5.849

9.  The 50 and 100-item short forms of the Paced Auditory Serial Addition Task (PASAT): demographically corrected norms and comparisons with the full PASAT in normal and clinical samples.

Authors:  Michael C Diehr; Mariana Cherner; Tanya J Wolfson; S Walden Miller; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2003-06       Impact factor: 2.475

Review 10.  Cognitive dysfunction in multiple sclerosis: a review of recent developments.

Authors:  Julie A Bobholz; Stephen M Rao
Journal:  Curr Opin Neurol       Date:  2003-06       Impact factor: 5.710

View more
  7 in total

1.  Prediction of driving ability in people with relapsing-remitting multiple sclerosis using the stroke driver screening assessment.

Authors:  Abiodun Emmanuel Akinwuntan; Christina O'Connor; Erin McGonegal; Kristen Turchi; Suzanne Smith; Mitzi Williams; Jerry Wachtel
Journal:  Int J MS Care       Date:  2012

Review 2.  Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.

Authors:  Uwe K Zettl; Paulus Rommer; Petra Hipp; Robert Patejdl
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

3.  The educational impact of childhood-onset multiple sclerosis: Why assessing academic achievement is imperative.

Authors:  W S Vargas; K G Noble; B Banwell; P De Jager
Journal:  Mult Scler       Date:  2020-05-28       Impact factor: 6.312

Review 4.  Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review.

Authors:  Alison Martin; Seye Abogunrin; Hannah Kurth; Jerome Dinet
Journal:  Neuropsychiatr Dis Treat       Date:  2014-01-23       Impact factor: 2.570

5.  Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery.

Authors:  Athanasios Papathanasiou; Lambros Messinis; Vasileios L Georgiou; Panagiotis Papathanasopoulos
Journal:  ISRN Neurol       Date:  2014-03-13

Review 6.  Shock waves in the treatment of muscle hypertonia and dystonia.

Authors:  Laura Mori; Lucio Marinelli; Elisa Pelosin; Antonio Currà; Luigi Molfetta; Giovanni Abbruzzese; Carlo Trompetto
Journal:  Biomed Res Int       Date:  2014-09-17       Impact factor: 3.411

Review 7.  The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity.

Authors:  Elisabeth G Celius; Carlos Vila
Journal:  Brain Behav       Date:  2018-04-06       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.